This is a preview of subscription content, log in via an institution to check access.
Reference
Gauthier G, et al. Economic Burden of HR+/HER2- Metastatic Breast Cancer Among Adult Premenopausal Women. Advances in Therapy : 20 Mar 2018. Available from: URL: http://doi.org/10.1007/s12325-018-0689-x
Rights and permissions
About this article
Cite this article
Premenopausal HR+/HER2− mBC has high economic burden. PharmacoEcon Outcomes News 800, 28 (2018). https://doi.org/10.1007/s40274-018-4847-9
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-018-4847-9